Lipoprotein (HDL)

High-density lipoproteins: the next frontier in lipid management.
[18928432] Med J Aust 189(8): 421-2 (2008)

Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets.
[16449520] Heart 93(5): 559-64 (2007)

High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.
[18629371] Vasc Health Risk Manag 4(1): 39-57 (2008)

Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium.
[17315398] Vasc Health Risk Manag 1(2): 119-29 (2005)

Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
[16968945] Pharmacol Rev 58(3): 342-74 (2006)

HDL-C as a new paradigm in atherosclerotic diseases.
[19585750] Indian J Physiol Pharmacol 52(4): 319-26 (2008)

High-density lipoproteins: an emerging target in the prevention of cardiovascular disease.
[17016470] Cell Res 16(10): 799-808 (2006)

Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications.
[19643035] BMB Rep 42(7): 393-400 (2009)

High-density lipoprotein: does it have a dark side?
[19014411] Arthritis Res Ther 10(5): 121 (2008)

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.
[18828865] Arthritis Res Ther 10(4): 213 (2008)

Oxidized LDL and HDL: antagonists in atherothrombosis.
[11641234] FASEB J 15(12): 2073-84 (2001)

The structure of apolipoprotein A-I in high density lipoproteins.
[17526499] J Biol Chem 282(31): 22249-53 (2007)

Assembly of high-density lipoprotein.
[16284193] Arterioscler Thromb Vasc Biol 26(1): 20-7 (2006)

High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease.
[15003970] Arterioscler Thromb Vasc Biol 24(3): 387-91 (2004)

Endothelial protection by high-density lipoproteins: from bench to bedside.
[12969988] Arterioscler Thromb Vasc Biol 23(10): 1724-31 (2003)

Antiinflammatory properties of HDL.
[15486323] Circ Res 95(8): 764-72 (2004)

Reverse cholesterol transport, high density lipoproteins and HDL cholesterol: recent data.
[12909808] Diabetes Metab 29(3): 201-5 (2003)

Molecular regulation of HDL metabolism and function: implications for novel therapies.
[17143322] J Clin Invest 116(12): 3090-100 (2006)

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
[2200802] J Clin Invest 86(2): 379-84 (1990)

HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects.
[17698855] J Lipid Res 48(11): 2325-33 (2007)

Thematic review series: patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans?
[16685079] J Lipid Res 47(8): 1631-42 (2006)

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
[15060092] J Lipid Res 45(6): 993-1007 (2004)

High density lipoprotein receptors, binding proteins, and ligands.
[9925647] J Lipid Res 40(2): 187-201 (1999)

Synthesis, transport, and processing of apolipoproteins of high density lipoproteins.
[6442339] J Lipid Res 25(13): 1586-92 (1984)

Sites and mechanisms of uptake and degradation of high density and low density lipoproteins.
[6397563] J Lipid Res 25(13): 1577-85 (1984)

High density lipoprotein metabolism.
[6392459] J Lipid Res 25(10): 1017-58 (1984)

High-density lipoprotein as a therapeutic target: a systematic review.
[17699012] JAMA 298(7): 786-98 (2007)

From menace to marvel: high-density lipoprotein prevents endothelial nitric oxide synthase uncoupling in diabetes mellitus by angiotensin II type 1 receptor downregulation.
[19273742] Hypertension 53(4): 587-9 (2009)

Liver X receptor activation and high-density lipoprotein biology: a reversal of fortune?
[16391165] Circulation 113(1): 5-8 (2006)

The complexity of high-density lipoproteins.
[20974995] Circulation 122(19): 1900-1 (2010)

Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition: an update for clinicians.
[15824213] Circulation 111(14): 1847-54 (2005)

Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins.
[21628835] Circ J 75(7): 1533-8 (2011)

Update on the role of endothelial lipase in high-density lipoprotein metabolism, reverse cholesterol transport, and atherosclerosis.
[20962428] Circ J 74(11): 2263-70 (2010)

Old drug, new tricks: the unexpected effect of doxazosin on high-density lipoprotein.
[17641233] Circ Res 101(2): 116-8 (2007)

New insights into the regulation of HDL metabolism and reverse cholesterol transport.
[15976321] Circ Res 96(12): 1221-32 (2005)

Endothelial and antithrombotic actions of HDL.
[16763172] Circ Res 98(11): 1352-64 (2006)

High-density lipoprotein function in regulating insulin secretion: possible relevance to metabolic syndrome.
[20631346] Arterioscler Thromb Vasc Biol 30(8): 1497-9 (2010)

A new dimension in the vasculoprotective function of HDL: progenitor-mediated endothelium repair.
[16627821] Arterioscler Thromb Vasc Biol 26(5): 965-7 (2006)

Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease.
[15319263] Arterioscler Thromb Vasc Biol 24(10): 1755-60 (2004)

Antiinflammatory actions of HDL: a new insight.
[18946054] Arterioscler Thromb Vasc Biol 28(11): 1890-1 (2008)

Of mice and men: blowing away the cobwebs from the mechanism of action of niacin on HDL metabolism.
[18946055] Arterioscler Thromb Vasc Biol 28(11): 1892-5 (2008)

Structure and function of HDL mimetics.
[19608977] Arterioscler Thromb Vasc Biol 30(2): 164-8 (2010)

Dysfunctional HDL as a diagnostic and therapeutic target.
[19679832] Arterioscler Thromb Vasc Biol 30(2): 151-5 (2010)

A role for the pregnane X receptor in high-density lipoprotein metabolism.
[16199756] Arterioscler Thromb Vasc Biol 25(10): 2016-7 (2005)

Cardioprotective effects of high-density lipoproteins: the evidence strengthens.
[15980266] Arterioscler Thromb Vasc Biol 25(7): 1305-6 (2005)

The molecular mechanisms of HDL and associated vesicular trafficking mechanisms to mediate cellular lipid homeostasis.
[19846837] Arterioscler Thromb Vasc Biol 29(11): 1718-22 (2009)

Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses.
[19797709] Arterioscler Thromb Vasc Biol 30(2): 139-43 (2010)

Understanding changes in high density lipoproteins during the acute phase response.
[16857958] Arterioscler Thromb Vasc Biol 26(8): 1687-8 (2006)

Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection.
[19233866] Cardiovasc Res 82(2): 201-11 (2009)

High-density lipoprotein mass, cholesteryl ester transport protein, and macrophage reverse cholesterol transport: from the bedside back to the bench.
[18187459] Cardiovasc Res 77(4): 614-5 (2008)

The role of high density lipoproteins in thrombosis.
[12806041] ScientificWorldJournal 2(-): 89-95 (2002)

Strategies to promote HDL-C: an emerging therapeutic target.
[15764616] Eur Heart J 26(9): 853-5 (2005)

Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database.
[19965573] J Lipid Res 51(6): 1546-53 (2010)

Genetic causes of high and low serum HDL-cholesterol.
[20421590] J Lipid Res 51(8): 2032-57 (2010)

The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
[20371550] J Lipid Res 51(8): 2058-73 (2010)

The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis.
[19023137] J Lipid Res 50 Suppl(-): S201-6 (2009)

The metabolism and anti-atherogenic properties of HDL.
[19033213] J Lipid Res 50 Suppl(-): S195-200 (2009)

Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
[15722558] J Lipid Res 46(3): 389-403 (2005)

The role of dysfunctional HDL in atherosclerosis.
[18955731] J Lipid Res 50 Suppl(-): S145-9 (2009)

Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma.
[19349471] J Clin Endocrinol Metab 94(4): 1081-3 (2009)

Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I.
[18753704] Endocr J 56(3): 317-34 (2009)

Laboratory assessment of HDL heterogeneity and function.
[18375481] Clin Chem 54(5): 788-800 (2008)

Therapies for raising high-density lipoprotein cholesterol.
[17409593] Intern Med 46(7): 339-40 (2007)

High-density lipoproteins: metabolic, clinical, epidemiological and therapeutic intervention aspects. An update for clinicians.
[17221046] Arq Bras Cardiol 87(5): 671-9 (2006)

HDL management: recent advances and perspectives beyond LDL reduction.
[17262119] Arq Bras Cardiol 87(6): 788-94 (2006)

Increasing high-density lipoprotein as a therapeutic target in atherothrombotic disease.
[20196993] Rev Esp Cardiol 63(3): 323-33 (2010)

High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.
[20059478] Clin Exp Immunol 160(2): 137-42 (2010)

Oxidized LDLs trigger endoplasmic reticulum stress and autophagy: prevention by HDLs.
[21412049] Autophagy 7(5): 541-3 (2011)

High density lipoprotein: it's not just about lipid transport anymore.
[21067941] Trends Endocrinol Metab 22(1): 9-15 (2011)

Obesity-related changes in high-density lipoprotein metabolism.
[18388903] Obesity (Silver Spring) 16(6): 1152-60 (2008)

HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders.
[20687877] Curr Pharm Des 16(28): 3173-84 (2010)

Roles of ATP-binding cassette transporter A7 in cholesterol homeostasis and host defense system.
[21173549] J Atheroscler Thromb 18(4): 274-81 (2011)

Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions.
[20513953] J Atheroscler Thromb 17(5): 436-51 (2010)

Antiatherogenic functionality of high density lipoprotein: how much versus how good.
[18385533] J Atheroscler Thromb 15(2): 52-62 (2008)

HDL as a biomarker, potential therapeutic target, and therapy.
[19940234] Diabetes 58(12): 2711-7 (2009)

Dysfunctional high-density lipoprotein.
[19306527] Curr Opin Endocrinol Diabetes Obes 16(2): 156-62 (2009)

Role of phospholipid transfer protein in high-density lipoprotein- mediated reverse cholesterol transport.
[21365262] Curr Atheroscler Rep 13(3): 242-8 (2011)

Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport.
[21424685] Curr Atheroscler Rep 13(3): 257-65 (2011)

Utility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies.
[21465111] Curr Atheroscler Rep 13(3): 277-84 (2011)

Apolipoprotein A-I mimetic peptides.
[19080728] Curr Atheroscler Rep 11(1): 52-7 (2009)

Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit.
[18553127] Cardiovasc Drugs Ther 22(4): 321-38 (2008)

The Effects of Very-Low-Calorie Diets on HDL: A Review.
[21490771] Cholesterol 2011(-): 306278 (2011)

The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.
[21490772] Cholesterol 2011(-): 496925 (2011)

The protein cargo of HDL: implications for vascular wall biology and therapeutics.
[20975842] J Clin Lipidol 4(5): 371-5 (2010)

Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.
[21537467] World J Biol Chem 1(11): 327-37 (2010)

New insights into the mechanism of low high-density lipoprotein cholesterol in obesity.
[21988829] Lipids Health Dis 10(-): 176 (2011)

The relationship between high density lipoprotein subclass profile and plasma lipids concentrations.
[20950490] Lipids Health Dis 9(-): 118 (2010)

Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein.
[20043647] Chem Res Toxicol 23(3): 447-54 (2010)

Nanobiotechnology applications of reconstituted high density lipoprotein.
[21122135] J Nanobiotechnology 8(): 28 (2010)

Human HDL containing a novel apoC-I isoform induces smooth muscle cell apoptosis.
[23354389] Cardiovasc Res 98(1):83-93 (2013)

Effect of HDL-raising drugs on cardiovascular outcomes: a systematic review and meta-regression.
[24728455] PLoS One 9(4):e94585 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lipoprotein (HDL).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Lipoprotein (HDL).php on line 92